NRCAM and papillary carcinoma: We did observe that tumours with more aggressive clinical behaviour (eg, pT4N1) tended to express higher levels of NrCAM, suggesting possible involvement of this molecule in regional spread – a characteristic feature of papillary carcinomas – but these differences were not statistically significant.